Mr. Irani was a Director of the Company since October 29, 1992. Mr. Irani was elected Chairman of the Board effective April 30, 1997, and was elected Chief Executive Officer effective October 24, 1997 until April 2004 when Mr. Barbieri was named parttime CEO. Mr. Irani was the Chief Executive Officer and Chairman of Biomerica since April 1997. Prior to that time, Mr. Irani served as Vice President of Business Development of Biomerica since July 1994 and Business Development Manager of Biomerica since 1986. Mr. Irani also serves as a Director of Biomerica. Mr. Irani was fully employed by the Company since June 2002
Irani is currently at the Lancer location one day per week, sharing executive management responsibilities with Mr. Barbieri. The remainder of his time is devoted to Biomerica.
Management Efficency
The company has return on total asset (ROA) of 0.48 % which means that it generated profit of $0.48 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of 3.31 % meaning that it generated $3.31 on every $100 dollars invested by stockholders.
Lancer Orthodontics, Inc. engages in the manufacture and worldwide marketing of orthodontic products. Lancer Orthodontics Inc [LANZ] is a Pink Sheet which is traded between brokers as part of OTC trading. Filter other
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory
1.03%
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Advice
